Plus Therapeutics, Inc. 与 Genomic Testing Cooperative 达成合作，旨在将下一代测序（NGS）技术整合到其Cnside®脑脊液（CSF）检测平台中。这一合作旨在增强该平台的分析能力，为中枢神经系统疾病提供更深入、更精准的基因组学见解。
Plus Therapeutics, Inc. 与 Genomic Testing Cooperative 达成合作，旨在将下一代测序（NGS）技术整合到其Cnside®脑脊液（CSF）检测平台中。这一合作旨在增强该平台的分析能力，为中枢神经系统疾病提供更深入、更精准的基因组学见解。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.